University of Phoenix Named to 2026 GSV 150 Bank of Idaho Finds Niche as PPP Lender
IDAHO FALLS, ID / ACCESSWIRE / April 9, 2021 / The SBA has projected that…
A Survivor Of Many Mental And Physical Trauma, Amanda Marino Knows What It Is Like To Overcome Impossible Tasks. That Is Why She Opened Her Business To Help Others
NEW YORK, NY / ACCESSWIRE / April 9, 2021 / Amanda Marino was able to…
Study Identifies New Role of BioAegis’ ‘Inflammation Regulator’ Gelsolin Relevant for a Range of Inflammatory Diseases
Gelsolin mitigates vascular damage by preventing release of IL-1β microparticles after trauma of high pressure…
Revive Provides Dial-In Information for Annual and Special Meeting
TORONTO, April 08, 2021 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE:…
Lexicon Pharmaceuticals to Participate in the 20th Annual Needham Virtual Healthcare Conference
THE WOODLANDS, Texas, April 08, 2021 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today…
Chinook Therapeutics to Present at Upcoming Investor Conferences
SEATTLE, April 08, 2021 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (NASDAQ: KDNY), a biopharmaceutical company…
Baudax Bio Announces Partial Adjournment of Annual Meeting of Shareholders
Annual Meeting to be adjourned solely with respect to Proposal 3 MALVERN, Pa., April 08,…
10x Genomics to Report First Quarter Financial Results on May 5, 2021
PLEASANTON, Calif., April 08, 2021 (GLOBE NEWSWIRE) — 10x Genomics (Nasdaq: TXG) today announced it…
Vascular Biogenics Ltd. Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants
TEL AVIV, Israel, April 08, 2021 (GLOBE NEWSWIRE) — Vascular Biogenics Ltd. (“VBL Therapeutics” or…
Chimerix Announces Upcoming Presentations at the American Association for Cancer Research Annual Meeting 2021
DURHAM, N.C., April 08, 2021 (GLOBE NEWSWIRE) — Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating…
Extension of lock-up period in Gilead-Galapagos collaboration agreement
Mechelen, Belgium; 08 April 2021; 22.01 CET; Galapagos (Euronext & Nasdaq; GLPG) announced today…
Onxeo to Present New Preclinical Data at AACR 2021
Confirming the effect of AsiDNA™ on resistance to KRAS inhibitors Introducing OX400, a new generation…
Tricida to Present at the Needham Virtual Healthcare Conference
SOUTH SAN FRANCISCO, Calif., April 08, 2021 (GLOBE NEWSWIRE) — Tricida, Inc. (Nasdaq: TCDA) today announced…
Aprea Therapeutics Receives FDA Orphan Drug Designation for Eprenetapopt for the Treatment of Acute Myeloid Leukemia (AML)
BOSTON, April 08, 2021 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company…
22nd Century Group Regulatory Science VP Joins FDLI Tobacco and Nicotine Products Committee
Another key indicator and milestone of the Increasing Importance of Reducing Cigarette Nicotine Content as…
NTG Nordic Transport Group A/S – Annual General Meeting 2021
Company announcement no 14 – 218 April 2021 NTG Nordic Transport Group A/S – Annual…
Todos Medical Receives Notice of Allowance from European Patent Office for Patent Application Covering Diagnosis of Cancer Using Proprietary Artificial Intelligence TBIA Immune Profiling Platform
NEW YORK, NY, and REHOVAT, ISRAEL, April 08, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Todos Medical,…
Last Chance for Children is Proud to Announce its Partnership with Generex Biotechnology & NuGenerex Immuno-Oncology to SAFELY and EFFECTIVELY Vaccinate Children and Pregnant Women
NEW YORK, April 08, 2021 (GLOBE NEWSWIRE) — Last Chance for Children’s (LCFC) Mission is…
Golden Leaf Holdings Completes Eighty Percent Acquisition of Plant-Based CBD Skincare Brand, Fifth & Root
PORTLAND, Ore., April 08, 2021 (GLOBE NEWSWIRE) — Golden Leaf Holdings Ltd. (CSE:GLH) (OTCQB:GLDFF) (“Golden…
Ocuphire Initiates ZETA-1 Phase 2 Clinical Trial Investigating APX3330 in Diabetic Retinopathy
APX3330 has the Potential to be a Novel Oral Treatment Option with Dual Mechanism of Anti-VEGF…